Matthew F. Mescher

Affiliations: 
University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Immunology, Cell Biology, Biochemistry
Website:
https://www.immunology.umn.edu/bio/center-for-immunology/matthew-mescher
Google:
"Matthew Franklin Mescher"
Bio:

http://www.pnas.org/content/73/8/2687.short

Mean distance: 3981.3
 

Parents

Sign in to add mentor
Jack L. Strominger grad student 1976 Harvard
 (The cell surface glycoprotein of Halobacterium salinarium.)

Children

Sign in to add trainee
Steve A. N. Goldstein grad student 1978-1986 Harvard
Clint S. Schmidt grad student 2000 UMN
Ee L. Tham grad student 2002 UMN
Javier O. Valenzuela grad student 2003 UMN
Jessica H. Bell grad student 2006 UMN
Pujya Agarwal grad student 2007 UMN
Christopher D. Hammerbeck grad student 2007 UMN
Flavia E. Popescu grad student 2007 UMN
Kerry A. Casey grad student 2009 UMN
Michael Y. Gerner grad student 2009 UMN
Derry C. Roopenian post-doc 1984 Harvard Medical School
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Anderson KL, Snyder KM, Ito D, et al. (2019) Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade. Melanoma Research
Anderson KL, Snyder KM, Ito D, et al. (2019) Abstract A051: Melanoma displays an evolutionarily conserved resistance to upregulation of prophagocytic signals and to CD47 blockade Cancer Immunology Research. 7
Anderson KL, Snyder KM, Lins D, et al. (2017) Abstract A65: Mechanisms of melanoma cell resistance to phagocytosis Cancer Immunology Research. 5
Anderson KL, Lins D, Volkmer J, et al. (2016) Abstract A143: Melanoma cell resistance to phagocytosis is unrelated to expression of conventional “eat-me/don't eat-me” signals Cancer Immunology Research. 4
Jha G, Miller JS, Curtsinger JM, et al. (2014) Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanoma. American Journal of Clinical Oncology. 37: 261-5
Anderson KL, Ito D, Lins DC, et al. (2014) Abstract 4082: CD47 blockade to enhance adaptive anti-tumor immune responses Cancer Research. 74: 4082-4082
Zumwalde NA, Domae E, Mescher MF, et al. (2013) ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation. Journal of Immunology (Baltimore, Md. : 1950). 191: 3681-93
Wang Y, Shaked I, Stanford SM, et al. (2013) The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity. 39: 111-22
Gerner MY, Heltemes-Harris LM, Fife BT, et al. (2013) Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control. Journal of Immunology (Baltimore, Md. : 1950). 191: 1011-5
Curtsinger JM, Agarwal P, Lins DC, et al. (2012) Autocrine IFN-γ promotes naive CD8 T cell differentiation and synergizes with IFN-α to stimulate strong function. Journal of Immunology (Baltimore, Md. : 1950). 189: 659-68
See more...